A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice.
暂无分享,去创建一个
Ming You | Yan Lu | Yukihiko Hara | Ying Yan | Yan Lu | M. You | Ying Yan | R. Lubet | Yian Wang | Ronald A Lubet | Ruisheng Yao | Yian Wang | Y. Hara | R. Yao
[1] S. Amin,et al. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. , 1992, Cancer research.
[2] G. Kelloff. Perspectives on cancer chemoprevention research and drug development. , 2000, Advances in cancer research.
[3] Ross Ihaka,et al. Gentleman R: R: A language for data analysis and graphics , 1996 .
[4] M. Suganuma,et al. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. , 2000, BioFactors.
[5] H Ishii,et al. Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.
[6] A. Albini,et al. Prostate carcinoma and green tea: (−)epigallocatechin‐3‐gallate inhibits inflammation‐triggered MMP‐2 activation and invasion in murine TRAMP model , 2004, International journal of cancer.
[7] Andy H. Lee,et al. Green tea consumption enhances survival of epithelial ovarian cancer , 2004, International journal of cancer.
[8] Guoying Liu,et al. NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..
[9] M. You,et al. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. , 2000, Cancer research.
[10] S. Hirohashi,et al. DNA methyltransferase expression and DNA methylation of CPG islands and peri‐centromeric satellite regions in human colorectal and stomach cancers , 2001, International journal of cancer.
[11] Jill P. Mesirov,et al. GeneCluster 2.0: an advanced toolset for bioarray analysis , 2004, Bioinform..
[12] S. Lam,et al. A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium , 2004, Clinical Cancer Research.
[13] P. Maliakal,et al. Inhibition of carcinogenesis by tea. , 1997, Nature.
[14] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[15] Ni Ai,et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.
[16] M. Sporn,et al. Recent advances in chemoprevention of cancer. , 1997, Science.
[17] U. Pastorino,et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.
[18] S. Lam,et al. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. , 2002, Journal of the National Cancer Institute.
[19] Chi-Tang Ho,et al. Green tea polyphenols , 2004 .
[20] H. Mukhtar,et al. Tea polyphenols: prevention of cancer and optimizing health. , 2000, The American journal of clinical nutrition.
[21] M. You,et al. Differential gene expression in chemically induced mouse lung adenomas. , 2003, Neoplasia.
[22] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[23] Clinical development plan: Tea extracts green tea polyphenols epigallocatechin gallate , 2002 .
[24] Steven C. Lawlor,et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.